Cover Image
市場調查報告書

MediPoint:神經血管介入 - 現在/未來的主要企業

MediPoint: Neurovascular Interventions - Current and Future Players

出版商 GlobalData 商品編碼 301165
出版日期 內容資訊 英文 188 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:神經血管介入 - 現在/未來的主要企業 MediPoint: Neurovascular Interventions - Current and Future Players
出版日期: 2014年04月30日 內容資訊: 英文 188 Pages
簡介

全球神經血管介入正以2位數的大幅速度在急速成長。由於神經介入技術與低侵入性治療技術急速進步,未來可治療的疾病也在日益增加。神經血管介入市場分為血管堵塞、血管再生、機械除去血栓、進入/支援等四個領域。

本報告提供腦血管疾病(顱內動脈瘤/動靜脈畸形,動脈粥狀硬化等)治療用的神經血管介入市場上主要企業相關資料,以新加入企業及上市產品,正在開發的開發中產品等競爭情形為焦點彙整其分析結果,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 競爭評估

  • 概要
  • 全球市場佔有率
  • 已上市產品(計29產品)

第4章 開發中產品的評估

  • 概要
  • 各開發階段的開發中產品
  • 產品簡介(計12產品)

第5章 現在·未來的主要企業

  • 概要
  • 企業策略的趨勢
  • 企業簡介(計30公司份)

第6章 附錄

圖表一覽

目錄
Product Code: GDME1025FPR

The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.

The report identifies and analyzes the key companies shaping and driving the Neurovascular Interventions market. The report provides insight into the competitive Neurovascular Interventions landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Neurovascular Interventions
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Neurovascular Interventions in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Neurovascular Interventions market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst

3. Competitive Assessment

  • 3.1. Overview
  • 3.2. Global Market Share
  • 3.3. Marketed Products
    • 3.3.1. Aachen Resonance
    • 3.3.2. Abbott Vascular
    • 3.3.3. Acandis
    • 3.3.4. B. Braun
    • 3.3.5. BALT Extrusion
    • 3.3.6. Blockade Medical
    • 3.3.7. Boston Scientific Corporation
    • 3.3.8. Contego Medical
    • 3.3.9. Cook Medical
    • 3.3.10. Covidien
    • 3.3.11. Gardia Medical
    • 3.3.12. Gore Medical
    • 3.3.13. InspireMD
    • 3.3.14. ITGI Medical
    • 3.3.15. Johnson & Johnson
    • 3.3.16. Medikit
    • 3.3.17. Medtronic
    • 3.3.18. Merlin MD
    • 3.3.19. MicroPort Scientific Corporation
    • 3.3.20. Minvasys
    • 3.3.21. Neuravi
    • 3.3.22. Optimed
    • 3.3.23. Penumbra
    • 3.3.24. Phenox GmbH
    • 3.3.25. Reverse Medical
    • 3.3.26. Sequent Medical
    • 3.3.27. Stryker Neurovascular Intervention
    • 3.3.28. Terumo Corporation
    • 3.3.29. Valor Medical

4. Pipeline Assessment

  • 4.1. Overview
  • 4.2. Pipeline by Stage of Development
  • 4.3. Product Profiles
    • 4.3.1. Aneurysm Occlusion Saddle
    • 4.3.2. Ballstent Microcatheter
    • 4.3.3. Blood Clot Removing Device
    • 4.3.4. EKOS' EkoSonic Small Vessel Endovascular System
    • 4.3.5. Flow-Diverting Thin-Film Nitinol Covered Stent
    • 4.3.6. Ischemic Stroke System
    • 4.3.7. Janjua Aneurysm Net
    • 4.3.8. Multilayer Aneurysm Repair System
    • 4.3.9. NAVIMAX
    • 4.3.10. Palmaz Scientific Stents
    • 4.3.11. Silk Road System
    • 4.3.12. Transcranial Thrombectomy Catheter

5. Current and Future Players

  • 5.1. Overview
  • 5.2. Trends in Corporate Strategy
  • 5.3. Company Profiles
    • 5.3.1. BALT Extrusion
    • 5.3.2. Covidien
    • 5.3.3. Johnson & Johnson
    • 5.3.4. Penumbra
    • 5.3.5. Stryker Corporation
    • 5.3.6. Terumo Corporation
    • 5.3.7. Abbott Vascular
    • 5.3.8. Boston Scientific Corporation
    • 5.3.9. Cook Medical
    • 5.3.10. Gore Medical
    • 5.3.11. Medtronic
    • 5.3.12. Aachen Resonance
    • 5.3.13. Acandis
    • 5.3.14. B. Braun
    • 5.3.15. Blockade Medical
    • 5.3.16. Contego Medical
    • 5.3.17. Gardia Medical
    • 5.3.18. InspireMD
    • 5.3.19. ITGI Medical
    • 5.3.20. Medikit
    • 5.3.21. Merlin MD
    • 5.3.22. MicroPort Scientific Corporation
    • 5.3.23. Minvasys
    • 5.3.24. Neuravi
    • 5.3.25. Optimed
    • 5.3.26. Phenox GmBH
    • 5.3.27. Reverse Medical
    • 5.3.28. Sequent Medical
    • 5.3.29. Valor Medical
    • 5.3.30. Other Companies

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Report Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Secondary Research
  • 6.4. Physicians and Specialists Included in this Study
    • 6.4.1. Vivek Gupta, MD
    • 6.4.2. Zsolt Kulscar, MD, PhD
    • 6.4.3. Salvatore Mangiafico, MD
    • 6.4.4. Thanh Nguyen, MD, FRCPc
    • 6.4.5. Eduardo Wajnberg, MD
    • 6.4.6. Phil White, MD
    • 6.4.7. Osama O Zaidat, MD, MS, FAAN, FAHA
  • 6.5. Primary Research
    • 6.5.1. Primary Research - Key Opinion Leader Interviews
    • 6.5.2. Expert Panel Validation
  • 6.6. Forecasting Methodology
  • 6.7. About the Authors
    • 6.7.1. Analysts
    • 6.7.2. Global Head of Healthcare
  • 6.8. About MediPoint
  • 6.9. About GlobalData
  • 6.10. Disclaimer

List of Tables

  • Table 1: Aachen Resonance Neurovascular Intervention Marketed Product
  • Table 2: Aachen Resonance Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 3: Abbott Vascular Neurovascular Intervention Marketed Products
  • Table 4: Abbott Vascular Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 5: Acandis Neurovascular Intervention Marketed Products
  • Table 6: Acandis Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 7: B. Braun Neurovascular Intervention Marketed Product
  • Table 8: B. Braun Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 9: BALT Extrusion Neurovascular Intervention Marketed Products
  • Table 10: BALT Extrusion Neurovascular Intervention Marketed Access Products
  • Table 11: BALT Extrusion Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 12: Blockade Medical Neurovascular Intervention Marketed Product
  • Table 13: Blockade Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 14: Boston Scientific Neurovascular Intervention Marketed Products
  • Table 15: Boston Scientific Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 16: Contego Medical Neurovascular Intervention Marketed Product
  • Table 17: Contego Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 18: Cook Medical Neurovascular Intervention Marketed Products
  • Table 19: Cook Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 20: Covidien Neurovascular Interventional Marketed Products
  • Table 21: Covidien Neurovascular Intervention Marketed Access Products
  • Table 22: Covidien Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 23: Gardia Medical Neurovascular Intervention Marketed Product
  • Table 24: Gardia Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 25: Gore Medical Neurovascular Intervention Marketed Products
  • Table 26: Gore Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 27: InspireMD Neurovascular Intervention Marketed Product
  • Table 28: InspireMD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 29: ITGI Medical Neurovascular Intervention Marketed Product
  • Table 30: ITGI Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 31: Codman Neurovascular Marketed Embolization Products
  • Table 32: Codman Neurovascular Marketed Mechanical Thrombectomy and Access Products
  • Table 33: Codman Neurovascular's (Codman & Shurtleff) Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 34: Cordis Corporation Marketed Neurointerventional Products
  • Table 35: Cordis Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 36: Medikit Neurovascular Intervention Marketed Products
  • Table 37: Medikit Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 38: Medtronic Neurovascular Intervention Marketed Products
  • Table 39: Medtronic Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 40: Merlin MD Neurovascular Intervention Marketed Product
  • Table 41: Merlin MD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 42: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products
  • Table 43: MicroPort Scientific Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 44: Minvasys Neurovascular Intervention Marketed Product
  • Table 45: Minvasys Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 46: Neuravi Neurovascular Intervention Marketed Product
  • Table 47: Neuravi Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 48: Optimed Neurovascular Intervention Marketed Products
  • Table 49: Optimed Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 50: Penumbra Neurovascular Intervention Marketed Products
  • Table 51: Penumbra Marketed Neurovascular Access Products
  • Table 52: Penumbra Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 53: Phenox GmbH Neurovascular Intervention Marketed Products
  • Table 54: Phenox GmbH Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 55: Reverse Medical Neurovascular Intervention Marketed Products
  • Table 56: Reverse Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 57: Sequent Medical Neurovascular Intervention Marketed Products
  • Table 58: Sequent Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 59: Stryker Neurovascular Intervention Marketed Products
  • Table 60: Stryker Neurovascular Intervention Marketed Mechanical Thrombectomy and Access Products
  • Table 61: Stryker Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 62: Terumo Europe N.V. and Terumo Interventional Systems Marketed Neurointerventional Products
  • Table 63: Terumo Corporation Neurovascular Product Portfolio SWOT Analysis, 2014
  • Table 64: MicroVention Neurovascular Intervention Marketed Products
  • Table 65: MicroVention Marketed Neurovascular Access Products
  • Table 66: MicroVention Neurovascular Product Portfolio SWOT Analysis, 2014
  • Table 67: Valor Medical Neurovascular Intervention Marketed Products
  • Table 68: Valor Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014
  • Table 69: Global Neurovascular Interventions Pipeline Products
  • Table 70: Aneurysm Occlusion Saddle SWOT Analysis, 2014
  • Table 71: EKOS EkoSonic SV System SWOT Analysis, 2014
  • Table 72: Flow-Diverting Thin-Film Nitinol Covered Stent SWOT Analysis, 2014
  • Table 73: Janjua Aneurysm Net SWOT Analysis, 2014
  • Table 74: Multilayer Aneurysm Repair System SWOT Analysis, 2014
  • Table 75: NAVIMAX SWOT Analysis, 2014
  • Table 76: Palmaz Scientific Stents SWOT Analysis, 2014
  • Table 77: Silk Road System SWOT Analysis, 2014
  • Table 78: BALT Extrusion Company Profile
  • Table 79: BALT Extrusion Neurovascular Intervention Marketed Products
  • Table 80: BALT Extrusion SWOT Analysis, 2014
  • Table 81: Covidien Company Profile
  • Table 82: Covidien Neurovascular Intervention Marketed Products
  • Table 83: Covidien SWOT Analysis, 2014
  • Table 84: Codman & Shurtleff Company Profile
  • Table 85: Codman & Shurtleff Neurovascular Intervention Marketed Products
  • Table 86: Codman & Shurtleff SWOT Analysis, 2014
  • Table 87: Cordis Corporation Company Profile
  • Table 88: Cordis Corporation Neurovascular Intervention Marketed Products
  • Table 89: Cordis Corporation SWOT Analysis, 2014
  • Table 90: Penumbra Company Profile
  • Table 91: Penumbra Neurovascular Intervention Marketed Products
  • Table 92: Penumbra SWOT Analysis, 2014
  • Table 93: Stryker Corporation Company Profile
  • Table 94: Stryker Corporation Neurovascular Intervention Marketed Products
  • Table 95: Stryker Corporation SWOT Analysis, 2014
  • Table 96: Terumo Corporation Company Profile
  • Table 97: Terumo Europe N.V. and Terumo Interventional Systems Neurovascular Intervention Marketed Products
  • Table 98: MicroVention Neurovascular Intervention Marketed Products
  • Table 99: Terumo Corporation SWOT Analysis, 2014
  • Table 100: Abbott Vascular Company Profile
  • Table 101: Abbott Vascular Neurovascular Intervention Marketed Products
  • Table 102: Abbott Vascular SWOT Analysis, 2014
  • Table 103: Boston Scientific Corporation Company Profile
  • Table 104: Boston Scientific Neurovascular Intervention Marketed Products
  • Table 105: Boston Scientific Corporation SWOT Analysis, 2014
  • Table 106: Cook Medical Company Profile
  • Table 107: Cook Medical Neurovascular Intervention Marketed Products
  • Table 108: Cook Medical SWOT Analysis, 2014
  • Table 109: Gore Medical Company Profile
  • Table 110: Gore Medical Neurovascular Intervention Marketed Products
  • Table 111: Gore Medical SWOT Analysis, 2014
  • Table 112: Medtronic Company Profile
  • Table 113: Medtronic Neurovascular Intervention Marketed Products
  • Table 114: Medtronic SWOT Analysis, 2014
  • Table 115: Aachen Resonance Company Profile
  • Table 116: Aachen Resonance Neurovascular Intervention Marketed Product
  • Table 117: Aachen Resonance SWOT Analysis, 2014
  • Table 118: Acandis Company Profile
  • Table 119: Acandis Neurovascular Intervention Marketed Products
  • Table 120: Acandis SWOT Analysis, 2014
  • Table 121: B. Braun Company Profile
  • Table 122: B. Braun Neurovascular Intervention Marketed Product
  • Table 123: B. Braun SWOT Analysis, 2014
  • Table 124: Blockade Medical Company Profile
  • Table 125: Blockade Medical Neurovascular Intervention Marketed Product
  • Table 126: Blockade Medical SWOT Analysis, 2014
  • Table 127: Contego Medical Company Profile
  • Table 128: Contego Medical Neurovascular Intervention Marketed Product
  • Table 129: Contego Medical SWOT Analysis, 2014
  • Table 130: Gardia Medical Company Profile
  • Table 131: Gardia Medical Neurovascular Intervention Marketed Product
  • Table 132: Gardia Medical SWOT Analysis, 2014
  • Table 133: InspireMD Company Profile
  • Table 134: InspireMD Neurovascular Intervention Marketed Product
  • Table 135: InspireMD SWOT Analysis, 2014
  • Table 136: ITGI Medical Company Profile
  • Table 137: ITGI Medical Neurovascular Intervention Marketed Product
  • Table 138: ITGI Medical SWOT Analysis, 2014
  • Table 139: Medikit Company Profile
  • Table 140: Medikit Neurovascular Intervention Marketed Products
  • Table 141: Medikit SWOT Analysis, 2014
  • Table 142: Merlin MD Company Profile
  • Table 143: Merlin MD Neurovascular Intervention Marketed Product
  • Table 144: Merlin MD SWOT Analysis, 2014
  • Table 145: MicroPort Scientific Corporation Company Profile
  • Table 146: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products
  • Table 147: MicroPort Scientific Corporation SWOT Analysis, 2014
  • Table 148: Minvasys Company Profile
  • Table 149: Minvasys Neurovascular Intervention Marketed Product
  • Table 150: Minvasys SWOT Analysis, 2014
  • Table 151: Neuravi Company Profile
  • Table 152: Neuravi Neurovascular Intervention Marketed Product
  • Table 153: Neuravi SWOT Analysis, 2014
  • Table 154: Optimed Company Profile
  • Table 155: Optimed Neurovascular Intervention Marketed Products
  • Table 156: Optimed SWOT Analysis, 2014
  • Table 157: Phenox GmBH Company Profile
  • Table 158: Phenox GmbH Neurovascular Intervention Marketed Products
  • Table 159: Phenox GmBH SWOT Analysis, 2014
  • Table 160: Reverse Medical Company Profile
  • Table 161: Reverse Medical Neurovascular Intervention Marketed Products
  • Table 162: Reverse Medical SWOT Analysis, 2014
  • Table 163: Sequent Medical Company Profile
  • Table 164: Sequent Medical Neurovascular Intervention Marketed Products
  • Table 165: Sequent Medical SWOT Analysis, 2014
  • Table 166: Valor Medical Company Profile
  • Table 167: Valor Medical Neurovascular Intervention Marketed Products
  • Table 168: Valor Medical SWOT Analysis, 2014
  • Table 169: Other Companies in the Neurovascular Intervention Market, 2014

List of Figures

  • Figure 1: Global Neurointerventional Market Distribution, 2013
  • Figure 2: Global Neurovascular Interventions Pipeline Products by Stage of Development, 2014
Back to Top